
	Three Months Ended July 3, 2026		Three Months Ended June 30, 2025		Six Months Ended July 3, 2026		Six Months Ended June 30, 2025
Numerator:
(Loss) income from continuing operations	$	(4,488)	$	2,130	$	(4,826)	$	3,983
Loss from discontinued operations	—		(890)		—		(1,546)
Net (loss) income	$	(4,488)	$	1,240	$	(4,826)	$	2,437
Denominator:
Weighted average shares outstanding – basic	28,414,861		20,123,187		24,223,725		20,123,187
Weighted average effect of potentially dilutive securities:
Effect of potentially dilutive securities	—		145,095		—		72,948
Weighted average shares outstanding – diluted	28,414,861		20,268,282		24,223,725		20,196,135
Net (loss) income per share – continuing operations:
Basic	$	(0.16)	$	0.11	$	(0.20)	$	0.20
Diluted	$	(0.16)	$	0.11	$	(0.20)	$	0.20
Net loss per share – discontinued operations:
Basic	$	—	$	(0.05)	$	—	$	(0.08)
Diluted	$	—	$	(0.05)	$	—	$	(0.08)
Net (loss) income per share:
Basic	$	(0.16)	$	0.06	$	(0.20)	$	0.12
Diluted	$	(0.16)	$	0.06	$	(0.20)	$	0.12

For the three months ended July 3, 2026, the weighted average shares outstanding – basic reflects 20,122,721 shares of common stock that were outstanding for the entire three month period, plus a weighted average of 9,857,142 shares issued upon execution of the IPO and 479,635 additional shares of common stock issued during the three months ended July 3, 2026, each weighted for the portion of the period such shares were outstanding. The Company reported a net loss for the period; therefore, the effect of all potential common shares was anti-dilutive and excluded from weighted average shares outstanding - diluted. Potential dilutive shares excluded from the computation of weighted average shares outstanding - diluted consisted of 457,390 restricted stock awards and 657,704 restricted stock units.

For the three months ended June 30, 2025, weighted average shares outstanding - basic includes 20,122,721 shares of Class A common stock and 466 shares of Class B common stock. For the three months ended June 30, 2025, weighted average shares outstanding - diluted included 145,095 incremental shares calculated under the treasury stock method, which reflects a weighted-average unrecognized compensation expense of $2.6 million associated with outstanding stock-based payment awards

For the six months ended July 3, 2026, weighted-average shares outstanding – basic reflects 20,122,721 shares of common stock that were outstanding for the entire six month period, plus a weighted average of 9,857,142 shares issued upon execution of the IPO and 479,635 additional shares of common stock issued during the six months ended July 3, 2026, each weighted for the portion of the period such shares were outstanding. The Company reported a net loss for the period; therefore, the effect of all potential common shares was anti-dilutive and excluded from weighted average shares outstanding - diluted. Potential dilutive shares excluded from the computation of diluted weighted average consisted of 457,390 restricted stock awards and 657,704 restricted stock units.

For the six months ended June 30, 2025, weighted average shares outstanding - basic includes 20,122,721 shares of Class A common stock of 20,122,721 shares and 466 shares of Class B common stock. For the six months ended June 30, 2025, the weighted average shares outstanding - diluted included 72,948 incremental shares calculated under the treasury stock method, which reflects a weighted-average unrecognized compensation expense of $1.1 million associated with outstanding stock-based payment awards.


	Three Months Ended				Six Months Ended
	July 3, 2026		June 30, 2025		July 3, 2026		June 30, 2025
Numerator:
Net (loss) income	$	(4,488)	$	1,240	$	(4,826)	$	2,437
Income tax effects of Reorganization(a)	—		(86)		3,791		(169)
Pro forma net (loss) income	$	(4,488)	$	1,154	$	(1,035)	$	2,268

Denominator:
Pro forma weighted average common stock outstanding – basic(b)	28,414,861		20,123,187		24,223,725		20,123,187
Pro forma weighted average common stock outstanding – diluted(b,c)	28,414,861		20,268,282		24,223,725		20,196,135

Pro forma net (loss) income per share – basic	$	(0.16)	$	0.06	$	(0.04)	$	0.11
Pro forma net (loss) income per share – diluted	$	(0.16)	$	0.06	$	(0.04)	$	0.11

(a)Following the Reorganization, the Company is subject to U.S. federal and applicable state income taxes. The adjustment for income taxes reflects the estimated income tax expense that would have been recognized had the Reorganization occurred on January 1, 2025, based on an effective tax rate of (91.5)% and (73.2)% for the three and six months ended July 3, 2026, and 6.95% for the three and six months ended June 30, 2025. No pro forma adjustment for income taxes was required for the three months ended July 3, 2026, as the Reorganization was already in effect for the entirety of that period, such that the Company's actual effective tax rate for the three months ended July 3, 2026 reflects its full corporate tax status without adjustment. The pro forma effective tax rate for the six months ended July 3, 2026 represents the Company's actual effective tax rate for the period, excluding the effect of the deferred tax adjustment of $3.5 million, which was recognized in the period of the Reorganization and does not reflect ongoing income tax expense, and other discrete tax impacts of $0.3 million related to the Reorganization. Because the Reorganization occurred during the three months ended April 3, 2026, these amounts are fully reflected within the six month period and no incremental adjustment relates to the three months ended July 3, 2026. For the three and six months ended June 30, 2025, the difference between the U.S. federal statutory rate of 21.0% and the effective tax rate of 6.95% is primarily driven by a 15.45% reduction due to federal tax credits, partially offset by other immaterial rate items of 1.4%, including state taxes and permanent differences. The pro forma income tax effect for the three and six months ended June 30, 2025 includes the results of discontinued operations.

(c)The potential impact on the pro forma weighted average common stock outstanding (diluted) of 657,704 shares of restricted stock units, 457,390 restricted stock awards, and 677,280 of stock appreciation rights were evaluated under the treasury stock method. There was no impact of dilutive shares for the three and six months ended July 3, 2026, as the Company operated at a net loss for both periods. For the three and six months ended June 30, 2025, the Company determined that the impact represented 145,095 and 72,948 dilutive shares, respectively, considering the weighted average unrecognized compensation costs of approximately $2.6 million and $1.1 million, respectively, and the estimated fair value of our common stock for the period.